Ikeda, Daniel J.
DeFilipp, Zachariah http://orcid.org/0000-0002-7994-8974
Collier, Kerry
Chen, Yi-Bin http://orcid.org/0000-0002-9554-1058
Dey, Bimalangshu R.
El-Jawahri, Areej http://orcid.org/0000-0002-3556-1495
Frigault, Matthew J.
Leick, Mark B. http://orcid.org/0000-0003-3111-0221
McAfee, Steven L.
Newcomb, Richard A.
O’Donnell, Paul V.
Spitzer, Thomas R. http://orcid.org/0000-0003-1384-5742
Article History
Received: 19 July 2023
Revised: 19 September 2023
Accepted: 4 October 2023
First Online: 11 October 2023
Competing interests
: Y-BC: Consulting for Incyte, Takeda, Magenta, Celularity, Novo Nordisk, and Astellas. Matthew JF: Consulting: Kite, Novartis, BMS, Iovance. Research: Arcellx, Novartis, Kite. Richard A. Newcomb: Equity was received from Timedoc in 2022 and 2023; the relationship now ended. Spouse equity received from Vertex Pharmaceuticals; relationship ongoing. Thomas R Spitzer: Bluebird Bio (Data Monitoring Committee), Ossium Health (Scientific Review Committee), Qihan Biotech (Scientific Advisory Board), Syneos Health (Data Monitoring and Adjudication Committees).